06/10/2015 - 14:19 The experimental radiopeptide therapy 177Lu-Dotatate looks poised to become a new treatment option for patients with midgut neuroendocrine tumors that Visit websiteField of Interest: OncologyNews Feed: Internal Medicine News - Oncology